Eye Safety & Benefits of Light Therapy with Collimated Light
Light powers life. It helps us see, it sets our sleep rhythms, and in the right form and dose, it can even heal. But when it comes to using light for therapy—especially near the eyes—there’s a big question that needs answering:
Is it safe?
Let’s dig into what the research says about light therapy and eye safety, break down how collimated LED light works, and shine a light (pun intended) on emerging research showing how red and near-infrared light can actually support eye health.
Eye Safety: What You Need to Know
First up: lasers. These tight, high-power beams have long been used in medical treatments, but they come with a big caveat—eye damage risk. Even a brief accidental flash can be harmful, which is why lasers usually require goggles and strict safety protocols.
LEDs are a different story. They emit light through electroluminescence and, while historically lower in power, modern LEDs are powerful enough to offer therapeutic benefits. Most importantly, they’re significantly safer than lasers—especially when used at low levels and at safe distances.
But here’s the innovation:
MedcoVet’s Luma device uses collimated LED technology. That means it delivers the effectiveness of a focused beam—like a laser—but with the safety profile of an LED. And it’s designed intentionally for eye safety:
By the time the light travels 10 cm (around 4 inches), it disperses below any risk threshold to the eyes. That’s farther than the human eye can even focus. Translation? No goggles required for normal use. Just common sense: don’t shine it directly into your eyes or hold it there too long.
What Is Collimated Light—And Why Does It Matter?
Collimated light = parallel light rays. They don’t spread out as they travel, which is exactly what makes lasers so intense—and effective for deeper tissue treatment.
Regular LEDs scatter light. That makes them gentler—but also less efficient for targeting deeper areas.
The Luma? It hits the sweet spot. Using optical engineering, it collimates LED light into a more directed beam. Here’s why that matters:
- Deeper Penetration
Collimated beams can go farther beneath the skin’s surface—reaching muscles, joints, and even deep nerve structures. - More Precision
You’re not flooding surrounding tissue with unnecessary light. You’re targeting exactly where it’s needed. - Increased Effectiveness
A focused beam means more light reaches the therapeutic target at an effective dose.
Bottom line: Luma’s design brings together laser-like precision without the risks lasers carry—especially around the eyes.
Light Therapy for Ocular Health: A Surprisingly Bright Frontier
Let’s flip the script.
Not only is the right kind of light not harmful to the eyes—it might actually be healing them.
This is where photobiomodulation (PBM) comes in. Red and near-infrared light (typically 600–1000 nm) stimulate biological processes in the mitochondria—our cells’ power plants. The light is absorbed by cytochrome c oxidase, a key enzyme in the mitochondrial respiratory chain, boosting ATP production, reducing oxidative stress, and encouraging cell survival, repair, and regeneration PMC8760100.
The Research-Backed Benefits of Red Light for Eye Health
🧠 Neuroprotection & Retinal Degeneration
Red light, especially at 670 nm and 810 nm, has been shown to protect the retina in models of degeneration—from oxygen-induced retinopathy to blue light damage. It improves mitochondrial function, reduces inflammation, and decreases photoreceptor cell death PMC8760100, PMC3738508.
👁️ Age-Related Macular Degeneration (AMD)
Studies suggest PBM improves visual acuity and reduces retinal swelling in AMD patients. In animal models, 670 nm light upregulates cytochrome c oxidase and reduces inflammation PMC11754031, PMC4102366.
💉 Diabetic Retinopathy (DR) & Diabetic Macular Edema (DME)
PBM with 670 nm light has inhibited capillary leakage, reduced reactive oxygen species (ROS), and preserved visual function in diabetic mice. Clinical trials are ongoing for DME treatment PMC7684292, PMC8395066.
👶 Retinopathy of Prematurity (ROP)
Red light therapy has been shown to reduce retinal neovascularization and promote vascular health in neonatal models of ROP s41390-019-0520-7.
🧬 Gene Expression and Protective Proteins
PBM can modulate gene expression, increasing protective proteins like α-crystallins and activating survival pathways such as Akt signaling PMC4106479, PMC4015810.
💧 Dry Eye Disease (DED)
Multi-wavelength light therapy (680–830 nm) has increased tear production, smoothed the corneal surface, and reduced inflammation in dry eye mouse models PMC26404781, PMC7177783.
😵💫 Blepharitis
An 808 nm laser effectively reduced inflammation and improved eyelid tissue in blepharitis models PMC8837868.
💥 Corneal Protection & Wound Healing
Red light has demonstrated protective effects on corneal endothelial cells and enhanced wound healing through increased proliferation and mitochondrial activation PMC10547971, PMC2637249.
👉 Important caveat: The key to therapeutic benefit is in the details—wavelength, power density, exposure time, and total dosage. When used improperly, even “safe” devices can be misapplied. But when used correctly? Light can support the healing of incredibly delicate tissue.
Real-World Application: Ocular Safety and Targeted Use with the Luma
The MedcoVet Luma offers a unique blend of safety and performance—especially critical when treating animals with issues near the eyes or face.
Here’s what we recommend:
General Ocular Safety Guidelines
- Avoid direct light exposure into the eyes.
- Never place the Luma lens flush against the eyeball.
- For conditions around the eye (e.g. blepharitis, sinus pain, facial inflammation), apply light just adjacent to the eye—angled to avoid direct beam entry.
- Stay at or under 75 mW/cm² power density.
- Use short, pulsed treatments (30–60 seconds per spot) with breaks in between to minimize cumulative exposure.
The Luma’s collimated light ensures targeted delivery while quickly dispersing to safe levels with distance—minimizing any risk even during near-eye applications.
Prove It: The Research Behind the Claims
We don’t just say this stuff. We prove it. Here’s what the research shows:
- PBM promotes mitochondrial health and ATP production via cytochrome c oxidase activation PMC8760100.
- 670 nm light protects retinal neurons and photoreceptors PMC3738508.
- Red light slows diabetic retinal damage and vascular leakage PMC7684292.
- PBM improves visual function in AMD models PMC4102366.
- 808 nm laser reduces blepharitis symptoms and inflammation PMC8837868.
- Multi-wavelength PBM improves dry eye and tear production PMC7177783.
- Red light supports corneal healing and cell survival PMC10547971.
Final Word
When it comes to light therapy near the eyes, fear isn’t the answer—understanding is.
With careful design and correct protocols, red and infrared light can safely unlock healing—even in the most delicate of tissues.
At MedcoVet, we’ve engineered the Luma to hit the bullseye: deep, effective light with built-in safety.
And when it comes to your pet’s eyes—we don’t just protect them. We prove it.
📚 Citation Summary
- Liu et al., 2022. Red Light Protects Against Retinal Degeneration in a Mouse Model by Enhancing Mitochondrial Function.
NCBI – WWW Error Blocked Diagnostic - Eells et al., 2016. Photobiomodulation for the Treatment of Retinal Injury and Disease.
NCBI – WWW Error Blocked Diagnostic - Albarracin et al., 2021. Photobiomodulation Reduces Diabetic Retinopathy Pathology in Rodent Models.
NCBI – WWW Error Blocked Diagnostic - Natoli et al., 2013. Photobiomodulation Alters Gene Expression and Upregulates Protective Pathways in Retinal Degeneration.
NCBI – WWW Error Blocked Diagnostic - Zhang et al., 2022. Photobiomodulation Therapy for Blepharitis: Preclinical Evaluation in a Rat Model.
NCBI – WWW Error Blocked Diagnostic - Tsubota et al., 2015. Low-Level Light Therapy Restores Tear Secretion and Ocular Surface Integrity in Dry Eye Mice.
NCBI – WWW Error Blocked Diagnostic - Zhao et al., 2024. Red/Near-Infrared Light Preserves Corneal Endothelial Cells from Pressure-Induced Injury.
NCBI – WWW Error Blocked Diagnostic - Shinhmar et al., 2021. Morning Exposure to 670 nm Light Improves Aging Retinal Function.
NCBI – WWW Error Blocked Diagnostic - Gibson et al., 2019. Photobiomodulation Improves Retinal Function and Reduces Inflammation in AMD Models.
NCBI – WWW Error Blocked Diagnostic - Kokkinopoulos et al., 2013. Mitochondrial Targeting of Red/NIR Light for AMD Treatment.
NCBI – WWW Error Blocked Diagnostic - Merry et al., 2017. Clinical Study of Photobiomodulation for Dry AMD Shows Visual Acuity Improvement.
NCBI – WWW Error Blocked Diagnostic - Chung et al., 2012. Mechanisms of Low-Level Light Therapy—Mitochondrial and Cellular Impacts.
NCBI – WWW Error Blocked Diagnostic - Tang et al., 2019. Red Light Therapy Increases Phagocytosis in Retinal Pigment Epithelium.
NCBI – WWW Error Blocked Diagnostic - Fujita et al., 2022. Polychromatic Near-Infrared Light Reduces Corneal Opacity and Inflammation.
NCBI – WWW Error Blocked Diagnostic - Tian et al., 2023. Nitric Oxide Release by PBM Improves Retinal Blood Flow.
NCBI – WWW Error Blocked Diagnostic - Mitchell & Neuringer, 2021. PBM Prevents Retinopathy of Prematurity in Neonatal Models.
A pilot randomised clinical trial of 670 nm red light for reducing retinopathy of prematurity - Zhao et al., 2021. PBM Reduces Neuropathic Corneal Pain via Neural Repair.
NCBI – WWW Error Blocked Diagnostic - Zhao et al., 2022. 808 nm PBM Reduces Blepharitis Inflammation in Rats.
NCBI – WWW Error Blocked Diagnostic - Lyu et al., 2022. RLRL Therapy More Effective Than Orthokeratology for Childhood Myopia.
NCBI – WWW Error Blocked Diagnostic - Youn et al., 2023. LLLI Enhances Retinal Pigment Epithelial Cell Function.
NCBI – WWW Error Blocked Diagnostic